Toshiaki Hanafusa
-
- Diabetes Management and Research 91
- Thyroid Disorders and Treatments 21
- Diabetes Treatment and Management 20
- Genetics top 0.1%
- Diabetes and associated disorders 127
- Immunology top 0.5%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 20
- Surgery top 0.2%
- Pancreatic function and diabetes 107
- Neurology top 1%
-
- Metabolism, Diabetes, and Cancer 19
- Co-authors
- Akihisa ImagawaRicardo Pujol‐BorrellYūji MatsuzawaJun‐ichiro MiyagawaMarc FeldmannGianFranco BottazzoKohjiro UekiYasuhiko Iwamoto
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Toshiaki Hanafusa
387 papers receiving 14.2k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Endocrinology, Diabetes and Metabolism 5.3k
- Genetics 5.3k
- Immunology 3.0k
- Surgery 5.1k
- Neurology 964
Countries citing papers authored by Toshiaki Hanafusa
This map shows the geographic impact of Toshiaki Hanafusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Hanafusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Hanafusa more than expected).
Fields of papers citing papers by Toshiaki Hanafusa
This network shows the impact of papers produced by Toshiaki Hanafusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Hanafusa. The network helps show where Toshiaki Hanafusa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiaki Hanafusa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2022 | 4 | |
| 3 | A case of fulminant type 1 diabetes patient accompanied by hyperinsulinemic hypoglycemia prior to clinical diagnosis of diabetes | 2016 | 4 |
| 4 | 2016 | 41 | |
| 5 | 2012 | 1 | |
| 6 | Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitusbreakdown → | 2010 | 1492 |
| 7 | 2010 | 12 | |
| 8 | 2008 | 10 | |
| 9 | 2008 | 75 | |
| 10 | 2007 | 8 | |
| 11 | 2007 | 27 | |
| 12 | 2007 | 4 | |
| 13 | 2006 | 15 | |
| 14 | 2005 | 1 | |
| 15 | 2005 | 92 | |
| 16 | 2004 | 5 | |
| 17 | 2001 | 0 | |
| 18 | 2000 | 45 | |
| 19 | [Mechanism of atherosclerosis in diabetes: altered cytokine network in the vascular wall]. | 1999 | 2 |
| 20 | 1991 | 7 |
About Toshiaki Hanafusa
Toshiaki Hanafusa is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Immunology, having authored 391 papers that have together received 14.7k indexed citations. Recurring topics across this work include Diabetes and associated disorders (127 papers), Pancreatic function and diabetes (107 papers), Diabetes Management and Research (91 papers), Thyroid Disorders and Treatments (21 papers), Immune Cell Function and Interaction (21 papers), Diabetes Treatment and Management (20 papers), T-cell and B-cell Immunology (20 papers) and Metabolism, Diabetes, and Cancer (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.3k citations), Genetics (5.3k citations) and Immunology (3.0k citations). Toshiaki Hanafusa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Akihisa Imagawa, Ricardo Pujol‐Borrell, Yūji Matsuzawa, Jun‐ichiro Miyagawa, Marc Feldmann, GianFranco Bottazzo, Kohjiro Ueki, Yasuhiko Iwamoto, Luca Chiovato and Masakazu Haneda. Their work appears in journals such as Nature, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.